trial group:Hi-chop
Sponsors
Peking University Cancer Hospital, Cancer center of Sun Yat-Sen University
Conditions
Diffuse large B-cell lymphomaNon-Hodgkin's lymphoma
Phase 2
A phase I/II clinical trail of recombinant chimeric human/murine anti CD20 monoclonal antibody in treatment of relapsed indolent CD20-positive B-cell non-Hodgkin Lymphoma.
Active, not recruitingChiCTR2100042103
Start: 2016-03-17Updated: 2021-04-12
A multicenter, randomized, single blind, multi dose, positive drug parallel controlled phase II clinical trial to evaluate the efficacy and safety of Hisun recombinant chimeric human-mouse anti-CD20 monoclonal antibody injection combined with CHOP (Hi CHOP) regimen in previously untreated patients with diffuse large B-cell 
Active, not recruitingChiCTR2100042104
Start: 2016-08-09Updated: 2021-04-12